SPDR S&P Biotech ETF
702 hedge funds and large institutions have $6.3B invested in SPDR S&P Biotech ETF in 2022 Q2 according to their latest regulatory filings, with 121 funds opening new positions, 249 increasing their positions, 196 reducing their positions, and 110 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
702
Holders Change
+3
Holders Change %
+0.43%
% of All Funds
11.87%
Holding in Top 10
32
Holding in Top 10 Change
+12
Holding in Top 10 Change %
+60%
% of All Funds
0.54%
New
121
Increased
249
Reduced
196
Closed
110
Calls
$1.8B
Puts
$1.78B
Net Calls
+$26.7M
Net Calls Change
-$52.4M
